SCARSI, Mirko
 Distribuzione geografica
Continente #
EU - Europa 2.421
NA - Nord America 1.806
AS - Asia 860
SA - Sud America 118
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.241
Nazione #
US - Stati Uniti d'America 1.763
IT - Italia 1.623
CN - Cina 306
SG - Singapore 306
DE - Germania 207
UA - Ucraina 163
FR - Francia 106
BR - Brasile 104
FI - Finlandia 80
HK - Hong Kong 80
GB - Regno Unito 70
RU - Federazione Russa 48
VN - Vietnam 48
TR - Turchia 33
IN - India 30
CA - Canada 27
IE - Irlanda 26
SE - Svezia 20
NL - Olanda 18
BD - Bangladesh 13
ZA - Sudafrica 13
ES - Italia 11
MX - Messico 11
IQ - Iraq 10
JP - Giappone 9
PL - Polonia 8
CH - Svizzera 7
AT - Austria 6
NG - Nigeria 6
AR - Argentina 5
EU - Europa 4
NP - Nepal 4
RO - Romania 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
JO - Giordania 3
MA - Marocco 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
ID - Indonesia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.241
Città #
Singapore 177
Ashburn 170
Fairfield 128
Jacksonville 119
Milan 119
Woodbridge 115
Rome 112
Ann Arbor 105
Beijing 103
Hong Kong 80
San Jose 74
Houston 71
Chandler 61
Wilmington 58
The Dalles 54
Seattle 53
Helsinki 52
New York 52
Cambridge 50
Princeton 50
Nanjing 40
Turin 40
Los Angeles 39
Munich 34
Bologna 33
Dallas 32
Brescia 28
Istanbul 26
Dublin 25
Lauterbourg 25
Florence 18
Des Moines 17
Ho Chi Minh City 17
Nanchang 17
Orem 17
Moscow 16
Mumbai 14
Verona 14
Dearborn 13
Genoa 13
Padova 13
Buffalo 12
Modena 12
São Paulo 12
Torino 12
Trieste 11
Montreal 10
Santa Clara 10
Sassari 10
Venice 10
Changsha 9
Hanoi 9
Hebei 9
Johannesburg 9
Naples 9
San Francisco 9
Shanghai 9
Shenyang 9
Reggio Nell'emilia 8
Tianjin 8
Tokyo 8
Bari 7
Boardman 7
Brooklyn 7
Jinan 7
Palermo 7
Redondo Beach 7
Trento 7
Turku 7
Chennai 6
Genova 6
Jiaxing 6
London 6
Manchester 6
Messina 6
Nürnberg 6
Perugia 6
Poplar 6
San Diego 6
Stockholm 6
Warsaw 6
Abuja 5
Ankara 5
Bergamo 5
Chicago 5
Duino-Aurisina 5
Ferrara 5
Frankfurt am Main 5
Hangzhou 5
Lanzhou 5
Vancouver 5
Vienna 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Capua 4
Castelnuovo Rangone 4
Catania 4
Cernobbio 4
Cisano Bergamasco 4
Totale 2.704
Nome #
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.837
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 204
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 186
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. 169
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 167
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 153
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 151
Impact of in utero environment on the offspring of lupus patients 149
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 149
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 147
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 140
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 138
Type I interferons in systemic autoimmunity. 133
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 133
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 132
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 125
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 117
REDUCTION OF PERIPHERAL BLOOD G-IFN AND IL-17 PRODUCING T CELLS AFTER THERAPY WITH ABATACEPT FOR RHEUMATOID ARTHRITIS 115
THE EFFECTS ON T-CELL IMMUNE PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH TWO DIFFERENT REGIMENS OF VITAMIN D SUPPLEMENTATION 115
Pregnancy in systemic sclerosis: a prospective study 114
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 113
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 112
REDUCTION OF T-CELL CLONAL EXPANSION IN RHEUMATOID ARTHRITIS PATIENTS AFTER 12 MONTHS OF ABATACEPT TREATMENT. 95
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 94
LOW NUMBERS OF CIRCULATING CD28 NEGATIVE T CELLS MAY BE A PREDICTIVE FACTOR OF A GOOD CLINICAL RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS 89
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 82
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 81
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial 70
Totale 5.310
Categoria #
all - tutte 18.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022484 22 47 13 40 20 63 40 44 34 52 48 61
2022/2023397 46 10 16 24 38 68 13 37 68 16 35 26
2023/2024344 21 9 25 36 21 58 16 23 55 7 29 44
2024/2025726 45 21 9 79 88 100 60 53 58 30 115 68
2025/20261.170 134 140 77 178 166 118 151 41 50 65 36 14
Totale 5.310